Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer

Overview of attention for article published in Cancer Nanotechnology, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#1 of 222)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 6 news outlets

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 17 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,536 followers.

@MedicalGenome Wasn't this data already published in July? https://t.co/AWms3BAN6Q $RNAZ

23 Sep 2021

Reply Repost Favourite

Here is the paper they published. https://t.co/0vMvDpKZdg

23 Sep 2021

Reply Repost Favourite

NEW: "Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer" https://t.co/kUJrC15fHf

09 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.